AVDL Annual Working Capital
$97.35 M
+$52.30 M+116.09%
31 December 2023
Summary:
As of January 22, 2025, AVDL annual working capital is $97.35 million, with the most recent change of +$52.30 million (+116.09%) on December 31, 2023. During the last 3 years, it has fallen by -$151.00 million (-60.80%). AVDL annual working capital is now -60.80% below its all-time high of $248.34 million, reached on December 31, 2020.AVDL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVDL Quarterly Working Capital
$84.47 M
+$3.31 M+4.08%
30 September 2024
Summary:
As of January 22, 2025, AVDL quarterly working capital is $84.47 million, with the most recent change of +$3.31 million (+4.08%) on September 30, 2024. Over the past year, it has dropped by -$12.87 million (-13.22%). AVDL quarterly working capital is now -67.34% below its all-time high of $258.68 million, reached on September 30, 2020.AVDL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVDL Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +116.1% | -13.2% |
| 3 y3 years | -60.8% | -29.4% |
| 5 y5 years | +12.6% | -29.4% |
AVDL Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.2% | +116.1% | -50.7% | +180.6% |
| 5 y | 5-year | -60.8% | +116.1% | -67.3% | +180.6% |
| alltime | all time | -60.8% | +1496.3% | -67.3% | +1311.6% |
Avadel Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $84.47 M(+4.1%) |
| June 2024 | - | $81.17 M(-8.0%) |
| Mar 2024 | - | $88.23 M(-9.4%) |
| Dec 2023 | $97.35 M(+116.1%) | $97.35 M(-17.6%) |
| Sept 2023 | - | $118.20 M(-1.3%) |
| June 2023 | - | $119.73 M(+297.6%) |
| Mar 2023 | - | $30.11 M(-33.2%) |
| Dec 2022 | $45.05 M(-73.7%) | $45.05 M(-37.2%) |
| Sept 2022 | - | $71.71 M(-9.8%) |
| June 2022 | - | $79.50 M(-31.9%) |
| Mar 2022 | - | $116.72 M(-31.9%) |
| Dec 2021 | $171.49 M(-30.9%) | $171.49 M(-8.9%) |
| Sept 2021 | - | $188.23 M(-12.2%) |
| June 2021 | - | $214.42 M(-8.0%) |
| Mar 2021 | - | $233.19 M(-6.1%) |
| Dec 2020 | $248.34 M(+435.3%) | $248.34 M(-4.0%) |
| Sept 2020 | - | $258.68 M(+3.5%) |
| June 2020 | - | $250.00 M(+153.5%) |
| Mar 2020 | - | $98.64 M(+112.6%) |
| Dec 2019 | $46.40 M(-46.3%) | $46.40 M(-18.4%) |
| Sept 2019 | - | $56.84 M(-10.7%) |
| June 2019 | - | $63.62 M(-10.5%) |
| Mar 2019 | - | $71.08 M(-17.8%) |
| Dec 2018 | $86.47 M(+131.0%) | $86.47 M(-14.3%) |
| Sept 2018 | - | $100.86 M(-18.2%) |
| June 2018 | - | $123.36 M(-14.8%) |
| Mar 2018 | - | $144.75 M(+286.7%) |
| Dec 2017 | $37.44 M(-68.5%) | $37.44 M(-27.5%) |
| Sept 2017 | - | $51.63 M(-55.4%) |
| June 2017 | - | $115.64 M(-4.1%) |
| Mar 2017 | - | $120.56 M(+1.5%) |
| Dec 2016 | $118.77 M(-2.0%) | $118.77 M(+0.1%) |
| Sept 2016 | - | $118.67 M(-0.7%) |
| June 2016 | - | $119.46 M(-0.1%) |
| Mar 2016 | - | $119.53 M(-1.3%) |
| Dec 2015 | $121.15 M(+192.1%) | $121.15 M(+52.6%) |
| June 2015 | - | $79.42 M(+53.7%) |
| Mar 2015 | - | $51.68 M(+24.6%) |
| Dec 2014 | $41.48 M(-695.0%) | $41.48 M(-19.5%) |
| Sept 2014 | - | $51.53 M(-23.4%) |
| June 2014 | - | $67.28 M(-5.8%) |
| Mar 2014 | - | $71.43 M(-1124.5%) |
| Dec 2013 | -$6.97 M(-165.0%) | -$6.97 M(+931.4%) |
| Sept 2013 | - | -$676.00 K(-103.8%) |
| June 2013 | - | $17.85 M(-30.6%) |
| Mar 2013 | - | $25.73 M(+139.9%) |
| Dec 2012 | $10.73 M | $10.73 M(-23.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $14.04 M(-9.0%) |
| Mar 2012 | - | $15.43 M(-15.9%) |
| Dec 2011 | $18.34 M(-29.3%) | $18.34 M(-18.1%) |
| Sept 2011 | - | $22.38 M(-3.0%) |
| June 2011 | - | $23.08 M(+25.1%) |
| Mar 2011 | - | $18.45 M(-28.9%) |
| Dec 2010 | $25.94 M(-41.0%) | $25.94 M(+0.2%) |
| Sept 2010 | - | $25.88 M(-10.0%) |
| June 2010 | - | $28.75 M(-20.8%) |
| Mar 2010 | - | $36.28 M(-17.4%) |
| Dec 2009 | $43.95 M(+12.9%) | $43.95 M(-8.0%) |
| Sept 2009 | - | $47.76 M(+11.6%) |
| June 2009 | - | $42.80 M(+7.4%) |
| Mar 2009 | - | $39.83 M(+2.3%) |
| Dec 2008 | $38.93 M(+25.0%) | $38.93 M(+25.4%) |
| Sept 2008 | - | $31.05 M(+3.6%) |
| June 2008 | - | $29.96 M(-4.5%) |
| Mar 2008 | - | $31.36 M(+0.7%) |
| Dec 2007 | $31.16 M(-43.8%) | $31.16 M(-9.9%) |
| Sept 2007 | - | $34.58 M(-8.1%) |
| June 2007 | - | $37.64 M(-22.2%) |
| Mar 2007 | - | $48.41 M(-12.7%) |
| Dec 2006 | $55.47 M(-17.3%) | $55.47 M(-5.6%) |
| Sept 2006 | - | $58.73 M(-3.4%) |
| June 2006 | - | $60.77 M(-4.1%) |
| Mar 2006 | - | $63.38 M(-5.5%) |
| Dec 2005 | $67.09 M(-31.1%) | $67.09 M(-16.2%) |
| Sept 2005 | - | $80.02 M(-7.3%) |
| June 2005 | - | $86.30 M(-13.7%) |
| Mar 2005 | - | $99.97 M(+2.6%) |
| Dec 2004 | $97.45 M(-5.3%) | $97.45 M(+5.8%) |
| Sept 2004 | - | $92.09 M(0.0%) |
| June 2004 | - | $92.09 M(-6.5%) |
| Mar 2004 | - | $98.47 M(-4.3%) |
| Dec 2003 | $102.87 M(+743.0%) | $102.87 M(+396.5%) |
| Sept 2003 | - | $20.72 M(+74.6%) |
| June 2003 | - | $11.87 M(-1.6%) |
| Mar 2003 | - | $12.06 M(-1.2%) |
| Dec 2002 | $12.20 M(+66.3%) | $12.20 M(-4.3%) |
| Sept 2002 | - | $12.75 M(+73.7%) |
| Dec 2001 | $7.34 M(-7.7%) | $7.34 M(-7.7%) |
| Dec 2000 | $7.95 M(+86.7%) | $7.95 M(+86.7%) |
| Dec 1999 | $4.26 M(-64.8%) | $4.26 M(-64.8%) |
| Dec 1998 | $12.08 M(+15.1%) | $12.08 M(+65.5%) |
| Mar 1998 | - | $7.30 M(-30.5%) |
| Dec 1997 | $10.50 M(-19.2%) | $10.50 M(-19.2%) |
| Dec 1996 | $13.00 M | $13.00 M(-784.2%) |
| Mar 1996 | - | -$1.90 M |
FAQ
- What is Avadel Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual working capital year-on-year change?
- What is Avadel Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly working capital year-on-year change?
What is Avadel Pharmaceuticals annual working capital?
The current annual working capital of AVDL is $97.35 M
What is the all time high annual working capital for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual working capital is $248.34 M
What is Avadel Pharmaceuticals annual working capital year-on-year change?
Over the past year, AVDL annual working capital has changed by +$52.30 M (+116.09%)
What is Avadel Pharmaceuticals quarterly working capital?
The current quarterly working capital of AVDL is $84.47 M
What is the all time high quarterly working capital for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly working capital is $258.68 M
What is Avadel Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, AVDL quarterly working capital has changed by -$12.87 M (-13.22%)